Saturday, October 13, 2012

The Economist on Global Fake and Substandard Pharmaceuticals

The Economist discusses the growing global problem of fake and substandard pharmaceuticals in Fake pharmaceuticals: Bad medicine -- The world's drug supply is global.  Governments have failed to keep up.  Absent from The Economist's discussion of government regulators and industry self-policing is the role of private litigation.  Couldn't emerging global tort litigation also deter wrongdoers and be part of the solution?

BGS

October 13, 2012 in Foreign, Pharmaceuticals - Misc., Products Liability | Permalink | Comments (0) | TrackBack (0)

Friday, October 12, 2012

Three Class-Action Cases to be Argued Before SCOTUS

Daniel Fisher at Forbes has an interesting article previewing three class-action cases being argued before the Supreme Court of the United States this fall: Class-Action Lawyers Face Triple Threat At Supreme Court.

BGS

October 12, 2012 in Aggregate Litigation Procedures, Class Actions, Procedure | Permalink | Comments (0) | TrackBack (0)

Possible BP Settlement with Federal Government Over Deepwater Horizon Gulf Oil Spill

Two Wall Street Journal articles in recent days have tracked recent settlements talks between BP and the federal government regarding civil and criminal liability in connection with the Deepwater Horizon oil spill in the Gulf.  On Wednesday, the Journal reported, BP Close to Spill Settlement: Multibillion-Dollar Deal With U.S. Would Combine Civil, Criminal Liabilities.  But on Thursday, the Journal noted in Slick Complicates BP Liability Talks that a new thin oil slick determined to be related to the prior Deepwater Horizon spill has appeared. 

BGS

October 12, 2012 in Environmental Torts, Mass Disasters, Settlement | Permalink | Comments (0) | TrackBack (0)

Compounding Pharmacy, Pharmaceutical Manufacturers, and the Fungal Meningitis Outbreak

A Wall Street Journal article, Pharmacy in Outbreak Acted Like Drug Maker, by Mark Maremont, Jonathan D. Rockoff, and Timony W. Martin explores the history of the companies allegedly involved in the fungal meningitis outbreak.  The article notes that a class action has already been filed in federal court in St. Paul, Minnesota.

BGS

October 12, 2012 in Pharmaceuticals - Misc., Products Liability, Regulation | Permalink | Comments (0) | TrackBack (0)

Wednesday, October 10, 2012

7th Annual ABA Chemical Products and Toxic Torts Regional Seminar

The seminar will take place in downtown New York at St. John's University School of Risk Management, on October 29, 2012.  Here's the brochure.

BGS

October 10, 2012 in Asbestos, Conferences | Permalink | Comments (1) | TrackBack (0)

Michael Downey on Ethical Issues Related to Incentive Payments for Class Representatives

As part of the ABA Sound Advice series, Michael Downey (Armstrong, Teasdale) addresses ethical issues related to incentive payments for class representatives.

BGS

October 10, 2012 in Class Actions, Ethics, Lawyers | Permalink | Comments (0) | TrackBack (0)

Christopher Robinette and American Law Institute

Congratulations to Torts Prof blogger Christopher Robinette (Widener) on being elected to the American Law Institute!  Having started together with him as Freedman fellows at Temple Law, I can also attest to his longstanding commitment to, and mastery of, tort law!  

BGS

October 10, 2012 in Lawyers, Mass Tort Scholarship | Permalink | Comments (0) | TrackBack (0)

Sunday, October 7, 2012

Mark Behrens on Philadelphia Tort Litigation

Mark Behrens (Shook, Hardy) has published Philadelphia Tort Litigation: Forum Shopping and Venue Reform as a Federalist Society white paper.

BGS

October 7, 2012 in Aggregate Litigation Procedures, Mass Tort Scholarship, Procedure | Permalink | Comments (0) | TrackBack (0)